Prostate Cancer Treatment Options

ì PROSTATE CANCER TREATMENT OPTIONS

99 Route 37 West Toms River, NJ 08755 (732) 557-‐3120 www.newjerseyck.com

PROSTATE CANCER OVERVIEW

ì  The prostate is located in a man’s lower abdomen and controls the flow of urine and semen.

ì  Second only to lung cancer, prostate cancer is the leading cause of cancer death among American men.

ì  According to the American Cancer Society, an esEmated 238,590 cases of prostate cancer will occur in the U.S. during 2013.


http://www.slideshare.net/newjerseyck/njck-acs-2013-data-overview

TREATING PROSTATE CANCER

ì  The stage of the cancer

ì  The patient’s age and health ì  The patient’s Gleason Score —

This determines how likely it is that a tumor will spread

ì  Whether the cancer is recently diagnosed or recurring

ì  The patient’s prostate-‐specific

antigen (PSA) levels — PSA is a substance made by the prostate that may be found in an increased amount in the blood of men who have prostate cancer

Prostate cancer treatments differ primarily in technical nature and potenEal side effects. Treatment options can depend on the following:


TREATMENT OPTIONS

ì  Prostate cancer treatment options include: ì  Active Surveillance

ì  Surgery ì  External-‐Beam Radiation Therapy ì  Brachytherapy

ì  Proton Therapy ì  Stereotactic Body Radiation Therapy


ACTIVE SURVEILLANCE

ì  The concept of acEve surveillance has emerged as a viable opEon for men who decide not to undergo immediate surgery or radiaEon therapy.


SURGERY

ì  Procedure & Recovery Time ì  Procedure lasts 3 – 4 hours ì  Requires general anesthesia and a three-‐

day hospital stay

ì  Recovery usually requires a few weeks at home

ì  Potential side effects

ì  Urinary incontinence ì  Erectile dysfunction

Radical Retropubic Prostatectomy: Surgery in which the prostate gland is removed and that may include biopsies of nearby lymph nodes; may be done robotically.


EXTERNAL-‐BEAM RADIATION THERAPY

ì  Procedure & Recovery Time ì  Approximately 40 daily radiaEon treatments over a period of seven to eight weeks ì  Treatment takes approximately 15 minutes ì  Outpatient procedure that allows most patients to return to their normal routine

ì  Potential side effects ì  Temporary rectal and urinary irritation

ì  Erectile dysfunction ì  Lacks the ability to correct for movement of the prostate during treatment,

resulting in possible damage to healthy tissue surrounding the prostate

Intensity Modulated Radiation Therapy or IMRT: IMRT targets radiation beams to the location of the patient’s tumor.


BRACHYTHERAPY

ì  Procedure & Recovery Time ì  One-‐Eme procedure that requires paEents to

remain in the hospital for several hours ì  PaEents are usually allowed to return home on

the same day

ì  Potential side effects ì  Erectile dysfunction ì  Urinary irritation, frequency and obstruction ì  Rectal injury

Brachytherapy: Small radioactive seeds are implanted within the prostate gland and give off radiation to the immediate surrounding area over the course of several months. After a year, the radioactive material degrades, and the seeds that remain are harmless.


PROTON THERAPY

ì  Procedure & Recovery Time ì  Treatment is usually delivered five days a week for

approximately eight weeks ì  PaEents are usually able to return to their normal rouEne

aVer treatment

ì  Potential side effects ì  Rectal and urinary irritation

Proton Therapy: Noninvasive treatment that uses a particle accelerator to deliver a focused ray of proton particles that destroy cancer cells.


STEREOTACTIC BODY RADIATION THERAPY

ì  Procedure & Recovery Time

ì  Five or fewer outpaEent sessions over the course of one to two weeks ì  Treatment procedures take about 30-‐90 minutes ì  PaEents are usually able to return to their normal rouEne aVer treatment ì  Recovery is often immediate

ì  Potential side effects

ì  Rectal and urinary irritation

Stereotactic Body Radiation Therapy: Noninvasive procedure that delivers targeted radiation beams to the prostate without incision or sedation using CyberKnife® technology.


CYBERKNIFE TREATMENT PROCESS

The treatment process includes:

ì  Consultation appointment

ì  Pretreatment procedures

ì  CyberKnife treatment

ì  Follow-‐up

Prior to stereotactic body radiosurgery treatment with CyberKnife, small tissue markers known as fiducials are implanted in the prostate to help the CyberKnife pinpoint the tumor location throughout each treatment, so the radiation beams can be locked on the tumor. About a week later, patients are fitted with a custom body mold of soft material that they lie on during treatments. The fitting process is painless.


http://www.youtube.com/watch?v=osvng4BkbQI

NEW JERSEY CYBERKNIFE TESTIMONIAL

“Convenience was extremely important to me. CyberKnife treatment took five sessions versus the 35 to 45 sessions I would have needed with other opEons. I travel for work and there’s no way I could be in the middle of treatment and go away for a week, come back and resume with the level of faEgue I’ve heard people can have with other treatments.

When I looked into CyberKnife, I saw the accuracy and number of treatments, and when I found out the side effects were so minimal, I thought it was the only way to go.

The New Jersey CyberKnife team was phenomenal. They were so courteous and its almost like checking into a hotel every day. I wouldn’t have chosen anything else.”

-‐ Gene G., New Jersey CyberKnife PaEent

OUR CENTER Opened in 2011, New Jersey CyberKnife at the J. Phillip Citta Regional Cancer Center is active in clinical research. Our state-‐of-‐the-‐art technology offers hope to patients in New Jersey and beyond. New Jersey CyberKnife opened aclinical trialsin collaboration with the University of Pittsburgh to evaluate stereotactic body radiation therapy for low, intermediate and high-‐risk prostate cancer patients. Results from the trial will add to the body of clinical research examining stereotactic body radiation therapy for prostate cancer and will help doctors analyze effects and outcomes to improve prostate treatment protocols. Medical Director Dr. David D’Ambrosio has also published several peer-‐reviewed research papers on prostate cancer. Our center provides the only CyberKnife technology in Ocean County, New Jersey.

Connect With Us

Medical Director: Dr. David Ambrosio Chairman of Radiation Oncology at Community Medical Center: Dr. Rajesh Iyer CyberKnife Nurse: Debbie Moriarty, RN, MSN, OCN


http://www.youtube.com/newjerseyck

http://www.flickr.com/people/newjerseyck

http://www.linkedin.com/company/new-jersey-cyberknife

Health & Medicine

Prostate Cancer Treatment Options